DISCUSSION QUESTIONS 1. You are the marketing manager for a national laboratory that has just come out with a blood test to screen for a rare genetic disease in fetuses of pregnant women. Because the test involves genetic screening, it is very expensive. Who are all the relevant stakeholders who will promote and block introduction of this test to this select population? 2. A newly popular type of insurance is a "consumer-directed health plan," where individuals have large deductibles to encourage prudent purchasing. Who is likely to sign up for these plans? From what you know about the RAND Health Insur- ance Experiment, is this approach likely to control health care costs? What are the drawbacks of such plans? 3. You are a territory manager for the cardiology division of a major medical device company. You notice that among the five largest cardiology groups in your area there is a threefold difference between lowest and highest use of your products. This finding is despite the fact that your competitor has not significantly penetrated this market. Using what you know about local area variations and physician behavior, what might explain this difference